Significance of serum Il-9 levels in inflammatory bowel disease

International Journal of Immunopathology and Pharmacology

Volumn 28, Issue 4, 2015, Pages 569-575

  Defendenti, Caterina ^a   Sarzi Puttini, Piercarlo ^b   Saibeni, Simone ^c   Bollani, Simona ^a   Bruno, Savino ^a   Almasio, Piero Luigi ^d   Declich, Paolo ^a   Atzeni, Fabiola ^e  

^a FATEBENEFRATELLI HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Guido Salvini Hospital   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

^e IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

Author keywords

inflammation; inflammatory bowel disease; interleukin; lymphocyte homing; lymphocytes; mucosal immunity

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 13 ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 9; IL6 PROTEIN, HUMAN; IL9 PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TH1 CELL; TH17 CELL; ULCERATIVE COLITIS; ADOLESCENT; BLOOD; IMMUNOLOGY; MIDDLE AGED; TH2 CELL;

ADOLESCENT; ADULT; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-6; INTERLEUKIN-9; MALE; MIDDLE AGED; TH17 CELLS; TH2 CELLS;

EID: 84946090320     PISSN: 03946320     EISSN: 20587384     Source Type: Journal    
DOI: 10.1177/0394632015600535     Document Type: Article

References (31)

1. Locksley RM, (2009) Nine lives: Plasticity among T helper cell subsets. Journal of Experimental Medicine 206: 1643-1646.
2. Naldi A, Carneiro J, Chaouija C, et al. (2010) Diversity and plasticity of Th cell types predicted from regulatory network modelling. PloS Computational Biology 6: e1000912.
3. Veldhoen M, Uyttenhove C, van Snick J, et al. (2008) Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nature Immunology 9: 1341-1346.
4. Romagnani S, (2006) Regulation of the T cell response. Clinical and Experimental Allergy 36: 1357-1366.
5. Beriou G, Bradshaw EM, Lozano E, et al. (2010) TGF-β induces IL-9 production from human TH17 cells. Journal of Immunology 185: 46-54.
6. Nagler-Anderson C, Bhan AK, Podolsky DK, et al. (2004) Control freaks: Immune regulatory cells. Nature Immunology 5: 119-122.
7. Lee YK, Turner H, Maynard CL, et al. (2009) Late developmental plasticity in the T helper 17 lineage. Immunity 30: 92-107.
8. Mauldin IS, Tung KS, Lorenz UM, (2012) The tyrosine phosphatase SHP-1 dampens murine Th17 development. Blood 119: 4419-4429.
9. Nowak EC, Weaver CT, Turner H, et al. (2009) IL-9 as a mediator of Th17-driven inflammatory disease. Journal of Experimental Medicine 206: 1653-1660.
10. Lu LF, Lind EF, Gondek DC, et al. (2006) Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442: 997-1002.
11. Neill DR, McKenzie ANJ, (2010) Th9: The latest addition to the expanding repertoire of IL-25 targets. Immunology and Cell Biology 88: 502-504.
12. Zaph C, Du Y, Saenz SA, et al. (2008) Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 Axis in the intestine. Journal of Experimental Medicine 205: 2191-2198.
13. Reynolds MJ, Angkasekwinai P, Dong C, (2010) IL-17 family member cytokines: Regulation and function in innate immunity. Cytokine Growth Factor Reviews 21: 413-423.
14. Walmsley RS, Ayres RC, Pounder RE, et al. (1998) A simple clinical colitis activity index. Gut 43: 29-32.
15. Lennard-Jones JE, (1989) Classification of inflammatory bowel disease. Scandinavian Journal of Gastroenterology Supplement 170: 2-6.
16. Best WR, Becktel JM, Singleton JW, et al. (1976) Development of a Crohn's disease activity index. Gastroenterology 70: 439-444.
17. Rachmilewitz D, (1998) Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial. British Medical Journal 298: 82-86.
18. Sartor RB, (2006) Mechanisms of disease: Pathogenesis of Crohn's disease and ulcerative colitis. Nature Clinical Practice Gastroenterology & Hepatology 3: 390-407.
19. Glas J, Wagner J, Seiderer J, et al. (2012) PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease background. PLoS One 7: 33682.
20. Scharl M, Hruz P, McCole DF, (2010) Protein tyrosine phosphatase non-receptor type 2 regulates IFN-3-induced cytokine signalling in THP-1 monocytes. Inflammatory Bowel Diseases 16: 2055-2064.
21. Scharl M, Paul G, Weber A, et al. (2009) Protection of epithelial barrier function by the Crohn's disease associated gene protein tyrosine phosphatase n2. Gastroenterology 137: 2030-2040.
22. Liu Z-J, Yadav PK, Su J-S, et al. (2009) Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease. World Journal of Gastroenterology 15: 5784-5788.
23. Del Zotto B, Mumolo G, Pronio AM, et al. (2003) TGF-β1 production in inflammatory bowel diseases: Differing production patterns in Crohn's disease and ulcerative colitis. Clinical and Experimental Immunology 134: 120-126.
24. Veldhoen M, Hocking RJ, Atkins CJ, et al. (2006) TGF-β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17 producing T cells. Immunity 24: 179-189.
25. Mahida YR, Kurlac L, Gallagher A, et al. (1991) High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut 32: 1531-1534.
26. Mitsuyama K, Sata M, Tanikawa K, (1991) Significance of interleukin-6 in patients with inflammatory bowel disease. Gastroenterologia Japonica 26: 20-28.
27. Mitsuyama K, Sata M, Rose-John S, (2006) Interleukin-6 trans-signaling in inflammatory bowel disease. Cytokine Growth Factor Reviews 17: 451-461.
28. Festen EAM, Goyette P, Scott R, et al. (2009) Genetic variants in the region harbouring IL2/IL21 associated to ulcerative colitis. Gut 58 (6): 799-804.
29. Berglund LJ, Avery DT, Ma CS, et al. (2013) IL-21 signalling via STAT3 primes human naïve B cells to respond to IL-2 to enhance their differentiation into plasmablasts. Blood 122: 3940-3950.
30. Su J, Chen T, Ji XY, et al. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease. Inflammatory Bowel Diseases 19: 720-728.
31. Fonseca-Camarillo G, Furuzawa-Carballeda J, Llorente L, et al. (2013) IL-10 and IL-20-expressing epithelial and inflammatory cells are increased in patients with ulcerative colitis. Journal of Clinical Immunology 33: 640-648.